Hansa Biopharma AB (HNSAN) Revenue
Hansa Biopharma AB Revenue
Hansa Biopharma AB had a revenue of 48.10M in the quarter ending Jun 30, 2026, with 39.13%. This bring the company's revenue in the last twelve months to 189.46M, Decreased 0.54%. In the fiscal year ending Dec 31, 2025, Hansa Biopharma AB had annual revenue of 222.26M with 29.74% growth.
- Revenue (ttm)
- 189.46M
- Revenue Growth
- -2.89%
- P/S Ratio
- 34.47
- Revenue/Employee
- MXN 1,696,679
- Employees
- 131
- Market Cap
- MXN 7.66B
Revenue Chart
Hansa Biopharma AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 222.26M | 50.95M | 29.74% |
| Dec 31, 2024 | 171.32M | 37.22M | 27.76% |
| Dec 31, 2023 | 134.09M | -20.43M | -13.22% |
| Dec 31, 2022 | 154.53M | 120.65M | 356.12% |
| Dec 31, 2021 | 33.88M | 27.78M | 455.56% |
| Dec 31, 2020 | 6.10M | 2.73M | 81.27% |
| Dec 31, 2019 | 3.36M | 6.00K | 0.18% |
| Dec 31, 2018 | 3.36M | -84.00K | -2.44% |
| Dec 31, 2017 | 3.44M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.